Organizations Filed Purposes:
The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) worked to reduce prescription drug fraud, diversion, misuse, and abuse while advancing consumer access to high-quality care for pain, addiction, HIV, hepatitis C, and other health conditions. CLAAD enabled health professionals, law enforcement, businesses, government officials, and others to share resources and work together to improve public health and safety. It fostered collaboration among the multiple sectors of society that had previously been working concurrently, yet not in unison, to address the growing national concern for prescription drug abuse. CLAAD gathered information and research on prescription drug abuse, misuse, and diversion. It coordinated grassroots activities among interested organizations and made policy recommendations on prescription drug abuse with the goal of improving public health.
The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) worked to reduce prescription drug fraud, diversion, misuse, and abuse while advancing consumer access to high-quality care for pain, addiction, HIV, hepatitis C, and other health conditions.
Information and analysis. CLAAD monitored legislation, policy making, scientific research, and current events related to prescription drug abuse and access to health care. It disseminated this information through the News section of its website, at national conferences and symposia, and via online forums, such as Twitter and LinkedIn. CLAAD spokespersons and coalition members provided analysis in the media as documented in the "CLAAD in the Media" section of its website. CLAAD began winding down these activities in the first quarter of 2018 and dissolved in April of 2018.
Coalition building. CLAAD collaborated with organizations and individuals interested in joining with allies to implement effective public health and safety policies at the local, state, and national levels. Its coalition members provided a wide array of expertise on the issues of prescription drug fraud, diversion, misuse, and abuse, and health care generally. The result of this unique collaboration was balance in research, policy analysis, and recommendations. CLAAD began winding down these activities in the first quarter of 2018 and dissolved in April 2018.
Policy leadership. CLAAD developed policy recommendations by gathering and synthesizing information, conducting original scholastic research, and drawing on the expertise of its coalition members. These policy recommendations were disseminated through CLAAD's work products, including its website, letters to policymakers, and white papers. CLAAD representatives also presented at several national conferences. CLAAD began winding down these activities in the first quarter of 2018 and dissolved in April 2018.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| J Kevin Massey | Director | 1 | $0 |
| Marsha Stanton Phd Rn | Director | 1 | $0 |
| Wade Delk | Director | 1 | $0 |
| Shari Hicks | Director | 1 | $0 |
| Alex Cahana Md | Director | 1 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202140639349301044_public.xml